Reporting owner · Q3 2026 · CIK 1992008

Chuang Hao-Yuan: insider trades.

Chuang Hao-Yuan reported 21 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 21 sales ($12.9M), across 1 company.

Transactions
21
Purchases (P)
0
Sales (S)
21
Companies
1
Name as filed
Chuang Hao-Yuan

Companies

CompanyRelationshipTransactions
Belite Bio, Inc (BLTE)Director, Officer · Chief Financial Officer21

Transactions

21 non-derivative rows. Shares and prices as filed.
DateCompanyCodeSharesPriceOwned afterFiling
2026-09-08Belite Bio, IncS2,562$198.0526,038Form 4
2026-09-08Belite Bio, IncS2,200$194.2841,800Form 4
2026-09-08Belite Bio, IncS4,120$195.637,680Form 4
2026-09-08Belite Bio, IncS4,475$196.4733,205Form 4
2026-09-08Belite Bio, IncS4,605$197.2328,600Form 4
2026-09-04Belite Bio, IncS1,633$180.1691,800Form 4
2026-09-04Belite Bio, IncS2,000$182.4987,800Form 4
2026-09-04Belite Bio, IncS3,759$183.2784,041Form 4
2026-09-04Belite Bio, IncS3,569$184.5780,472Form 4
2026-09-04Belite Bio, IncS3,872$185.2876,600Form 4
2026-09-04Belite Bio, IncS4,600$186.3572,000Form 4
2026-09-04Belite Bio, IncS3,900$187.1668,100Form 4
2026-09-04Belite Bio, IncS1,900$188.5966,200Form 4
2026-09-04Belite Bio, IncS6,200$189.2260,000Form 4
2026-09-04Belite Bio, IncS1,800$190.6358,200Form 4
2026-09-04Belite Bio, IncS6,200$191.0952,000Form 4
2026-09-04Belite Bio, IncS3,398$192.448,602Form 4
2026-09-04Belite Bio, IncS4,602$193.1244,000Form 4
2026-09-04Belite Bio, IncS2,000$181.0589,800Form 4
2026-08-12Belite Bio, IncS144$18093,656Form 4
2026-08-12Belite Bio, IncS223$180.5793,433Form 4

Questions

What stock did Chuang Hao-Yuan buy or sell?

Chuang Hao-Yuan reported 21 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 21 sales ($12.9M), across 1 company.

Is Chuang Hao-Yuan the same person as other filers with this name?

This page covers SEC CIK 1992008 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.

Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.

Plain-text version for agents and LLMs: /insiders/chuang-hao-yuan-1992008.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.